Different simulated instances with different values of <i>M.</i>

Different simulated instances with different values of <i>M.</i>

<p>Different simulated instances with different values of <i>M.</i></p>

Saved in:

Bibliographic Details
Main Author:	Sarmad Sohaib (21273402) (author)
Other Authors:	Muhammad Ahmad (3514832) (author), Muhammad Shafi (7168253) (author)
Published:	2025
Subjects:	Neuroscience Biotechnology Space Science Environmental Sciences not elsewhere classified Biological Sciences not elsewhere classified Mathematical Sciences not elsewhere classified Information Systems not elsewhere classified minor random alteration intelligent reflecting surfaces good &# 8221 bad &# 8221 phase shift matrix psm )- based sbf algorithm adjusts based phase adjustment based algorithm phase adjustment &# 8220 phase adjustments xlink "> throws away simulation results sends back results show predefined psm output signal noise ratio irs elements irs element irs ). indicating whether bit feedback
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Two simulated instances with <i>M</i> = 16.
by: Sarmad Sohaib (21273402)
Published: (2025)

BER curve using Monte-Carlo simulation for <i>M</i> = 4 with different codebook lengths.
by: Sarmad Sohaib (21273402)
Published: (2025)

BER comparison among PSM-based feedback algorithm, SBF algorithm, and perfect CSI using Monte-Carlo simulation.
by: Sarmad Sohaib (21273402)
Published: (2025)

Generalized architecture of an IRS system.
by: Sarmad Sohaib (21273402)
Published: (2025)

IRS-assisted system model.
by: Sarmad Sohaib (21273402)
Published: (2025)

Kaplan-Meier curves for overall survival (OS) and recurrence-free survival (RFS) from sensitivity analyses Kaplan-Meier curves comparing outcomes between <i>C.sinensis</i>-positive and <i>C.sinensis</i>-negative groups after adjustment using different propensity score methods.
by: Shuang Shen (185897)
Published: (2025)

A. Unadjusted Overall Survival (OS) by <i><i>C.sinensis</i></i> Infection Status. B. Unadjusted Recurrence-Free Survival (RFS) by <i><i>C.sinensis</i></i> Infection Status.
by: Shuang Shen (185897)
Published: (2025)

Comparison of baseline clinicopathological characteristics between <i>C.sinensis</i>-positive and <i>C.sinensis</i>-negative patients undergoing hepatectomy for HCC.
by: Shuang Shen (185897)
Published: (2025)

Baseline characteristics and survival analysis by <i>C.sinensis</i> diagnostic subgroup.
by: Shuang Shen (185897)
Published: (2025)

Multivariable cox regression analysis of the interaction between <i>C.sinensis</i> and HBsAg status on overall survival.
by: Shuang Shen (185897)
Published: (2025)

Path diagram illustrating the mediation analysis of the effect of <i>C.sinensis</i> infection on overall survival (OS) through microvascular invasion (MVI), The analysis was adjusted for a comprehensive set of nine baseline covariates: age, sex, HBsAg status, liver cirrhosis, BCLC stage, albumin, AFP, tumor size, and tumor number.
by: Shuang Shen (185897)
Published: (2025)

Univariable and multivariable cox regression analysis of factors associated with recurrence-free survival in hepatocellular carcinoma patients.
by: Shuang Shen (185897)
Published: (2025)

Univariable and multivariable cox regression analysis of factors associated with overall survival in hepatocellular carcinoma patients.
by: Shuang Shen (185897)
Published: (2025)

Propensity Score Matching (PSM) 1:1 (Caliper 0.02) Analysis Results.
by: Shuang Shen (185897)
Published: (2025)

Flowchart of patient inclusion and exclusion.
by: Shuang Shen (185897)
Published: (2025)

Sensitivity analyses: Doubly robust estimation and E-value analysis.
by: Shuang Shen (185897)
Published: (2025)

Covariate balance after inverse probability of treatment weighting.
by: Shuang Shen (185897)
Published: (2025)

Covariate balance after 1:3 propensity score matching.
by: Shuang Shen (185897)
Published: (2025)

Covariate balance after 1:1 propensity score matching.
by: Shuang Shen (185897)
Published: (2025)

Comparison of baseline characteristics between included and excluded cohorts.
by: Shuang Shen (185897)
Published: (2025)

Minimal dataset.
by: Shuang Shen (185897)
Published: (2025)

Reconfigurable Infrared (IR) Emissivity of VO<sub>2</sub> Patterns Fabricated via Maskless Laser Writing for Adaptive IR Applications
by: Hemadri Bandhu (20724362)
Published: (2025)

Supplementary material
by: Ting Song (314229)
Published: (2024)

<b>Cholesterol taste avoidance in </b><b><i>Drosophila melanogaster</i></b>
by: Roshani Nhuchhen Pradhan (20625197)
Published: (2025)

Association between METS-IR and hypertension in different sensitivity analyses.
by: Chun-Fang Ma (20074122)
Published: (2025)

The relationship between structure counts as defined in Table 1 is provided in a tree format in different stages of implementation.
by: Anne C. Martin (9346828)
Published: (2025)

Figure 1 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation
by: Qiang Zhao (22246789)
Published: (2025)

Figure 2 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation
by: Qiang Zhao (22246789)
Published: (2025)

Figure 3 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation
by: Qiang Zhao (22246789)
Published: (2025)

Figure 4 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation
by: Qiang Zhao (22246789)
Published: (2025)

Figure 5 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation
by: Qiang Zhao (22246789)
Published: (2025)

Figure S1 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation
by: Qiang Zhao (22246789)
Published: (2025)

Figure S2 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation
by: Qiang Zhao (22246789)
Published: (2025)

Table 1 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation
by: Qiang Zhao (22246789)
Published: (2025)

Table 2 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation
by: Qiang Zhao (22246789)
Published: (2025)

Figure 1 from First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors
by: Omid Hamid (15023912)
Published: (2025)

Figure 2 from First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors
by: Omid Hamid (15023912)
Published: (2025)

Figure 3 from First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors
by: Omid Hamid (15023912)
Published: (2025)

Table 1 from First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors
by: Omid Hamid (15023912)
Published: (2025)

Table 2 from First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors
by: Omid Hamid (15023912)
Published: (2025)

Cannot write session to /tmp/vufind_sessions/sess_jlmu3o8ktuvadfrm57i05k39fi